PHARMACEUTICAL DOSAGE FORM WHICH CAN BE ADMINISTERED ORALLY AND HAS MODIFIED RELEASE

The invention relates to pharmaceutical dosage forms, which can be administered orally and have a modified release and contain sodium (3S)-3-(4-chloro-3-phenyl-{[(2S,3R)-2-(4-chlorophenyl)-4,4,4-trifluoro-3-methylbutanoyl]amino}phenyl)-3-cyclopropylpropanoate, and to processes for preparing the dosa...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: OLENIK, Britta, LOBBACK, Carmen, GROSSBACH, Danja, BIERER, Donald, RUBENBAUER, Philipp, SERNO, Peter, STROYER, Anke, KÜSEL, Julia, LOVIS, Kai, SCHIRMER, Heiko, JACOBS, Tia
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator OLENIK, Britta
LOBBACK, Carmen
GROSSBACH, Danja
BIERER, Donald
RUBENBAUER, Philipp
SERNO, Peter
STROYER, Anke
KÜSEL, Julia
LOVIS, Kai
SCHIRMER, Heiko
JACOBS, Tia
description The invention relates to pharmaceutical dosage forms, which can be administered orally and have a modified release and contain sodium (3S)-3-(4-chloro-3-phenyl-{[(2S,3R)-2-(4-chlorophenyl)-4,4,4-trifluoro-3-methylbutanoyl]amino}phenyl)-3-cyclopropylpropanoate, and to processes for preparing the dosage forms and to the use thereof for treating and/or preventing diseases, in particular for treating and/or preventing cardiac, renal, pulmonary and ophthalmological disorders, disorders of the central nervous system, fibrotic and inflammatory disorders and metabolic diseases.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_SG11202100369WA</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>SG11202100369WA</sourcerecordid><originalsourceid>FETCH-epo_espacenet_SG11202100369WA3</originalsourceid><addsrcrecordid>eNqNyr0KwjAUQOEsDqK-wx1chaQFwfGa3DSB_EiSUpxKkTiJFur7o4MP4HTg46xZuRhMHiX1xUp0oGLGjkDH5GEwVhqQGOBMgMrbYHOhRApiQueugEGBwQw-Kqvt1xM5wkxbtrpPj6Xuft2wvaYizaHOr7Eu83Srz_oecydEwxvBeXs8Ddj-uX0ACNcxBg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PHARMACEUTICAL DOSAGE FORM WHICH CAN BE ADMINISTERED ORALLY AND HAS MODIFIED RELEASE</title><source>esp@cenet</source><creator>OLENIK, Britta ; LOBBACK, Carmen ; GROSSBACH, Danja ; BIERER, Donald ; RUBENBAUER, Philipp ; SERNO, Peter ; STROYER, Anke ; KÜSEL, Julia ; LOVIS, Kai ; SCHIRMER, Heiko ; JACOBS, Tia</creator><creatorcontrib>OLENIK, Britta ; LOBBACK, Carmen ; GROSSBACH, Danja ; BIERER, Donald ; RUBENBAUER, Philipp ; SERNO, Peter ; STROYER, Anke ; KÜSEL, Julia ; LOVIS, Kai ; SCHIRMER, Heiko ; JACOBS, Tia</creatorcontrib><description>The invention relates to pharmaceutical dosage forms, which can be administered orally and have a modified release and contain sodium (3S)-3-(4-chloro-3-phenyl-{[(2S,3R)-2-(4-chlorophenyl)-4,4,4-trifluoro-3-methylbutanoyl]amino}phenyl)-3-cyclopropylpropanoate, and to processes for preparing the dosage forms and to the use thereof for treating and/or preventing diseases, in particular for treating and/or preventing cardiac, renal, pulmonary and ophthalmological disorders, disorders of the central nervous system, fibrotic and inflammatory disorders and metabolic diseases.</description><language>eng</language><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS ; CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20210225&amp;DB=EPODOC&amp;CC=SG&amp;NR=11202100369WA$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76318</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20210225&amp;DB=EPODOC&amp;CC=SG&amp;NR=11202100369WA$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>OLENIK, Britta</creatorcontrib><creatorcontrib>LOBBACK, Carmen</creatorcontrib><creatorcontrib>GROSSBACH, Danja</creatorcontrib><creatorcontrib>BIERER, Donald</creatorcontrib><creatorcontrib>RUBENBAUER, Philipp</creatorcontrib><creatorcontrib>SERNO, Peter</creatorcontrib><creatorcontrib>STROYER, Anke</creatorcontrib><creatorcontrib>KÜSEL, Julia</creatorcontrib><creatorcontrib>LOVIS, Kai</creatorcontrib><creatorcontrib>SCHIRMER, Heiko</creatorcontrib><creatorcontrib>JACOBS, Tia</creatorcontrib><title>PHARMACEUTICAL DOSAGE FORM WHICH CAN BE ADMINISTERED ORALLY AND HAS MODIFIED RELEASE</title><description>The invention relates to pharmaceutical dosage forms, which can be administered orally and have a modified release and contain sodium (3S)-3-(4-chloro-3-phenyl-{[(2S,3R)-2-(4-chlorophenyl)-4,4,4-trifluoro-3-methylbutanoyl]amino}phenyl)-3-cyclopropylpropanoate, and to processes for preparing the dosage forms and to the use thereof for treating and/or preventing diseases, in particular for treating and/or preventing cardiac, renal, pulmonary and ophthalmological disorders, disorders of the central nervous system, fibrotic and inflammatory disorders and metabolic diseases.</description><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS</subject><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyr0KwjAUQOEsDqK-wx1chaQFwfGa3DSB_EiSUpxKkTiJFur7o4MP4HTg46xZuRhMHiX1xUp0oGLGjkDH5GEwVhqQGOBMgMrbYHOhRApiQueugEGBwQw-Kqvt1xM5wkxbtrpPj6Xuft2wvaYizaHOr7Eu83Srz_oecydEwxvBeXs8Ddj-uX0ACNcxBg</recordid><startdate>20210225</startdate><enddate>20210225</enddate><creator>OLENIK, Britta</creator><creator>LOBBACK, Carmen</creator><creator>GROSSBACH, Danja</creator><creator>BIERER, Donald</creator><creator>RUBENBAUER, Philipp</creator><creator>SERNO, Peter</creator><creator>STROYER, Anke</creator><creator>KÜSEL, Julia</creator><creator>LOVIS, Kai</creator><creator>SCHIRMER, Heiko</creator><creator>JACOBS, Tia</creator><scope>EVB</scope></search><sort><creationdate>20210225</creationdate><title>PHARMACEUTICAL DOSAGE FORM WHICH CAN BE ADMINISTERED ORALLY AND HAS MODIFIED RELEASE</title><author>OLENIK, Britta ; LOBBACK, Carmen ; GROSSBACH, Danja ; BIERER, Donald ; RUBENBAUER, Philipp ; SERNO, Peter ; STROYER, Anke ; KÜSEL, Julia ; LOVIS, Kai ; SCHIRMER, Heiko ; JACOBS, Tia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_SG11202100369WA3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2021</creationdate><topic>ACYCLIC OR CARBOCYCLIC COMPOUNDS</topic><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>OLENIK, Britta</creatorcontrib><creatorcontrib>LOBBACK, Carmen</creatorcontrib><creatorcontrib>GROSSBACH, Danja</creatorcontrib><creatorcontrib>BIERER, Donald</creatorcontrib><creatorcontrib>RUBENBAUER, Philipp</creatorcontrib><creatorcontrib>SERNO, Peter</creatorcontrib><creatorcontrib>STROYER, Anke</creatorcontrib><creatorcontrib>KÜSEL, Julia</creatorcontrib><creatorcontrib>LOVIS, Kai</creatorcontrib><creatorcontrib>SCHIRMER, Heiko</creatorcontrib><creatorcontrib>JACOBS, Tia</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>OLENIK, Britta</au><au>LOBBACK, Carmen</au><au>GROSSBACH, Danja</au><au>BIERER, Donald</au><au>RUBENBAUER, Philipp</au><au>SERNO, Peter</au><au>STROYER, Anke</au><au>KÜSEL, Julia</au><au>LOVIS, Kai</au><au>SCHIRMER, Heiko</au><au>JACOBS, Tia</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PHARMACEUTICAL DOSAGE FORM WHICH CAN BE ADMINISTERED ORALLY AND HAS MODIFIED RELEASE</title><date>2021-02-25</date><risdate>2021</risdate><abstract>The invention relates to pharmaceutical dosage forms, which can be administered orally and have a modified release and contain sodium (3S)-3-(4-chloro-3-phenyl-{[(2S,3R)-2-(4-chlorophenyl)-4,4,4-trifluoro-3-methylbutanoyl]amino}phenyl)-3-cyclopropylpropanoate, and to processes for preparing the dosage forms and to the use thereof for treating and/or preventing diseases, in particular for treating and/or preventing cardiac, renal, pulmonary and ophthalmological disorders, disorders of the central nervous system, fibrotic and inflammatory disorders and metabolic diseases.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_SG11202100369WA
source esp@cenet
subjects ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title PHARMACEUTICAL DOSAGE FORM WHICH CAN BE ADMINISTERED ORALLY AND HAS MODIFIED RELEASE
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T22%3A06%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=OLENIK,%20Britta&rft.date=2021-02-25&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ESG11202100369WA%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true